We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Roquefort Therapeutics Plc | LSE:ROQ | London | Ordinary Share | GB00BMDQ2T15 | ORD 1P |
Price Change | % Change | Share Price | Bid Price | Offer Price | |
---|---|---|---|---|---|
0.55 | 14.47% | 4.35 | 4.30 | 4.40 |
High Price | Low Price | Open Price | Shares Traded | Last Trade |
---|---|---|---|---|
4.40 | 4.35 | 4.40 | 522,137 | 08:37:31 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
Cmp Integrated Sys Design | 200k | -1.75M | -0.0135 | -3.22 | 4.91M |
Date | Time | Source | Headline |
---|---|---|---|
07/11/2024 | 07:00 | UK RNS | Roquefort Therapeutics PLC Conversion of Convertible Loan Notes |
06/11/2024 | 07:00 | UK RNS | Roquefort Therapeutics PLC STAT-6 siRNA Presentation |
27/9/2024 | 12:56 | ALNC | EARNINGS: Kendrick Resources loss narrows; Emmerson CFO to depart |
27/9/2024 | 06:00 | UK RNS | Roquefort Therapeutics PLC Interim Results to 30 June 2024 |
23/9/2024 | 16:51 | ALNC | Roquefort Therapeutics says MK cell therapy patent approved in Japan |
23/9/2024 | 06:00 | UK RNS | Roquefort Therapeutics PLC Grant of Japan MK Cell Patent |
19/9/2024 | 06:00 | UK RNS | Roquefort Therapeutics PLC STAT-6 siRNA Demonstrates Efficacy in Immunology |
02/9/2024 | 06:00 | UK RNS | Roquefort Therapeutics PLC Grant of MK Cell Patent & Licencing Update |
27/6/2024 | 11:46 | UK RNS | Roquefort Therapeutics PLC Results of AGM |
20/6/2024 | 06:00 | UK RNS | Roquefort Therapeutics PLC Appointment of Broker |
1 Year Roquefort Therapeutics Chart |
Intraday Roquefort Therapeutics Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions